Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(1578/week)
    • Manufacturing(769/week)
    • Energy(617/week)
    • Technology(1476/week)
    • Other Manufacturing(562/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Chiesi

Oct 18, 2024
Chiesi launches innovation platform focused on partnership and patient care: The Impulse
Jan 09, 2024
Chiesi Group and Oak Hill Bio announce License and Development Agreement to develop, manufacture, and commercialise OHB-607, a potentially transformative neonatal therapy
Feb 23, 2021
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Positive Topline Results from BRIGHT Phase III Open-Label, Switch-Over Clinical Trial Evaluating Pegunigalsidase Alfa 2 mg/kg every Four Weeks for Treatment of Fabry Disease
Feb 10, 2021
Protalix BioTherapeutics and Chiesi Global Rare Diseases Present Key Clinical Data of Pegunigalsidase Alfa for the Treatment of Fabry Disease at the 17th Annual WORLDSymposium(TM) 2021
Dec 30, 2020
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Final Results of BRIDGE Phase III Open-Label, Switch-Over Clinical Trial Evaluating Pegunigalsidase Alfa for the Treatment of Fabry Disease
Nov 27, 2020
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Extension of PDUFA Date for Pegunigalsidase Alfa for the Proposed Treatment of Fabry Disease
Aug 24, 2020
Protalix BioTherapeutics Announces Completion of the Treatment Period for its Phase III BRIGHT Clinical Trial of Pegunigalsidase Alfa (PRX-102) for the Proposed Treatment of Fabry Disease

Latest News

May 13, 2025

Kodiak Gas Services Announces Closing of Sale of Common Stock by Selling Stockholder Pursuant to Rule 144

May 13, 2025

EdgeCortix Becomes First Japanese and Semiconductor Company Awarded U.S. Defense Innovation Unit Contract

May 13, 2025

HNI Corporation Increases Quarterly Dividend

May 13, 2025

Largo Announces Results of its Annual General Meeting of Shareholders

May 13, 2025

Exchange Income Corporation Generates Record First Quarter Results and Reiterates Fiscal 2025 Guidance

May 13, 2025

Indiana American Water Proudly Recognizes American Water Charitable Foundation 2025 Water and Environment...

May 13, 2025

Chemtrade Logistics Income Fund Announces Financial Results for the First Quarter of 2025 and Raises Guidance...

May 13, 2025

EVI Industries Reports Record Results for the Three and Nine-Month Periods Ended March 31, 2025

View all News

Agenda

23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
21
May
United KingdomLondon, UK
Space Operations Summit, 21 - 22 May 2025, London, UK
Space Operations Summit | 21 - 22 May, 2025 | London, UK Space Operations Summit 2025 is the only conference to look at...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia